The Medicine Maker

Home
United Kingdom
Knutsford
The Medicine Maker

Monthly publication for professionals involved in development and manufacture of bio/pharmaceuticals.

Monthly publication with focus on clinical, regulatory, development and manufacturing fields for bio/pharmaceuticals.

24/09/2025

⏳ Just 1 week left until our free webinar: From lab to launch – innovating life science and diagnostics product development.

Join us on Wednesday, October 1 to explore how chemistry and biology breakthroughs are shaping the future of diagnostics and drug development.

🌟 Highlights:
🔹 Precision glycosylation modulation
🔹 Advanced biocatalysis for sustainable API synthesis
🔹 Real-world translation from discovery to product launch

Expert speakers:
🎙Thanos Andreou, Global NPI Process Manager, Biosynth
🎙Jan Modregger, Director of Biocatalysis, Biosynth
🎙Aileen White, Synthetic Chemistry Team Leader, Biosynth

📅 Spots are filling fast — register today: https://ow.ly/fzqQ50WLV2B

Sponsored by Biosynth

23/09/2025

🧫 Ready to strengthen your biologics workflows?

Join Charles River Labs experts Sha'land Abbott-Torrao and Manfred Suckow on October 16 for a must-attend webinar on microbial cell banking and characterization.

You will walk away with:
🔍 Practical strategies to generate and test microbial cell banks
📏 Insights into regulatory expectations and how to meet them
🧬 Best practices for release and advanced characterization testing
💡 The role of NGS and communication with regulators in ensuring success

📅 October 16, 2025 | 10AM EST | 4PM CET
🔗 Reserve your spot: https://ow.ly/zjyO50WQXf4

Do not miss this chance to gain actionable insights that will help your lab boost compliance, efficiency, and confidence in regulatory submissions.

19/09/2025

How can pharma minimize nitrosamine risk?

We interviewed Amit Chivate, Senior Area Marketing Manager for Greater Asia and China at Roquette Health & Pharma Solutions who shared why excipient selection, process control, and early-stage risk assessments are critical to patient safety.

He also discusses:
✅ Why early risk assessment is the toughest step
✅ The role of excipient suppliers in reducing risk
✅ How AI and predictive modeling could transform mitigation strategies

Read the full interview here 👉 https://ow.ly/5arU50WIahJ

17/09/2025

💡 What happens when you take drug development out of the lab — and into orbit?

In our latest Q&A, we sit down with Eric Lasker, Chief Revenue Officer at Varda Space Industries, to explore how crystallizing APIs and biologics in microgravity could change the future of medicine.

From uniform crystal structures and improved bioavailability to the possibility of reformulating biologics like monoclonal antibodies for easier administration — Eric shares how Varda is building the first commercial orbital labs outside the ISS and what that means for pharmaceutical innovation.

With $187M in Series C funding fueling expansion, including a new 10,000 sq. ft. facility, the company is poised to make space a key step in the drug development pipeline.

👉 Read the full Q&A: https://ow.ly/uiNM50WQh9W

15/09/2025

❓ Have you registered yet?

Our free webinar From lab to launch – innovating life science and diagnostics product development is just around the corner.

📅 Wednesday, October 1
💡 From precision glycosylation to biocatalysis, discover how breakthroughs move from the lab bench to real-world products.

Featuring:
🎙Thanos Andreou, Global NPI Process Manager, Biosynth
🎙Jan Modregger, Director of Biocatalysis, Biosynth
🎙Aileen White, Synthetic Chemistry Team Leader, Biosynth

🚨 Don’t miss your chance to hear directly from the experts.
👉 Secure your spot now: https://ow.ly/fzqQ50WLV2B

Sponsored by Biosynth

12/09/2025

📢 Our latest issue is here! Print copies will be landing on desks shortly 📰

✨ Inside this issue:
🔹 A cover feature on the complexities of the fill-finish step in pharma manufacturing
🔹 How to align sustainability goals with complex supply chains
🔹 Why oligonucleotides are gaining so much traction in drug discovery
🔹 A look inside a phase III trial for a potential first new TB vaccine in 100+ years
🔹 An exclusive interview with Cindy Perettie, Kite (a Gilead company)

👉 Get your FREE digital copy here: https://themedicinemaker.com/issues/2025/0825/

11/09/2025

🚨 Contamination is costly. Regulatory setbacks are too.

That is why mastering microbial cell banking and characterization is critical for biologics manufacturers.

Join experts Sha'land Abbott-Torrao and Manfred Suckow from Charles River Laboratories for an exclusive webinar on October 16.

What you will learn:
✅ Best practices for microbial cell bank generation and testing
✅ How to navigate regulatory guidelines with confidence
✅ Key methods for release and characterization testing
✅ The role of NGS and effective communication with regulators

📅 October 16, 2025 | 10AM EST | 4PM CET

🔗 Register now: https://ow.ly/xsQE50WQXhN

10/09/2025

🌍 Embedding Sustainability in Drug Development

Sustainability is no longer optional in pharma — it’s a business imperative. From greener packaging and smarter logistics to sustainable clinical trials, the industry is making real strides toward a more responsible future.

Our new eBook brings together the latest developments and success stories, with insights from leaders including Hanns-Christian Mahler, Michael Mrachacz, Thierry Escudier, and more.

📖 Download now to explore how CDMOs and partners are embedding sustainability across the value chain: https://ow.ly/jrEO50WPtFX

Special thanks to our sponsors for making this possible:
Actylis | Ecolab | CPI | Kindeva Drug Delivery | GEA

09/09/2025

⏰ Only 1 day left to register!

Are you ready to unlock higher yields in biologics manufacturing?

Tomorrow, join Erin Weisenhorn, Senior Scientist II at Just - Evotec Biologics, for an exclusive webinar on how metabolomic characterization of a perfusion bioprocess system can:

🔬 Provide deeper insights into CHO cell physiology
📈 Optimize media development
💡 Improve culture performance and yield

📅 September 10, 2025
🕒 8:00 am PST | 11:00 am EST | 4:00 pm BST | 5:00 pm CET

👉 Don’t miss out – register today: https://ow.ly/VYSP50WMEcl

05/09/2025

📢 Have you saved your spot yet?

On September 10, join Erin Weisenhorn, Senior Scientist II at Just – Evotec Biologics, to explore how metabolomic characterization can take CHO cell cultures to the next level.

What you’ll learn:
🔬 How metabolomics reveals deeper insights into cell physiology
📈 Strategies to optimize media development
💡 Ways to boost culture performance and yield

🕒 8:00 am PST | 11:00 am EST | 4:00 pm BST | 5:00 pm CET

👉 Secure your place today: https://ow.ly/VYSP50WMEcl

03/09/2025

Join us for a free webinar on Wednesday, October 1 and explore how advances in chemistry and biology are reshaping life sciences and diagnostics.

🌟 Topics include:
🔹 Precision glycosylation modulation
🔹 Advanced biocatalysis for sustainable API synthesis
🔹 Translating discovery into real-world applications

🎙 Speakers:
Thanos Andreou, Global NPI Process Manager, Biosynth
Jan Modregger, Director of Biocatalysis, Biosynth
Aileen White, Synthetic Chemistry Team Leader, Biosynth

📅 Save your spot today: https://ow.ly/PSA950WLV16

Sponsored by Biosynth

01/09/2025

⚡ Don’t miss this chance to boost your bioprocessing know-how!

On September 10, The Medicine Maker hosts a free webinar with Erin Weisenhorn, Senior Scientist II at Just – Evotec Biologics, on how metabolomic characterization of CHO cell cultures can:

🔬 Improve understanding of cell physiology
📈 Drive smarter media development
💡 Increase yield and culture performance

🕒 8:00 am PST | 11:00 am EST | 4:00 pm BST | 5:00 pm CET

👉 Register now: https://ow.ly/llRr50WMEEM

Address

Booths Park 1 Chelford Road
Knutsford
WA168

Telephone

+441565745200

Website

http://www.themedicinemaker.com/

Alerts

Be the first to know and let us send you an email when The Medicine Maker posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.